[go: up one dir, main page]

ES2178759T3 - Derivados de acido hidroxamico. - Google Patents

Derivados de acido hidroxamico.

Info

Publication number
ES2178759T3
ES2178759T3 ES97909339T ES97909339T ES2178759T3 ES 2178759 T3 ES2178759 T3 ES 2178759T3 ES 97909339 T ES97909339 T ES 97909339T ES 97909339 T ES97909339 T ES 97909339T ES 2178759 T3 ES2178759 T3 ES 2178759T3
Authority
ES
Spain
Prior art keywords
compounds
formula
acid derivatives
hydroxamic acid
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97909339T
Other languages
English (en)
Inventor
Georg Kottirsch
Ulf Neumann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9620572.9A external-priority patent/GB9620572D0/en
Priority claimed from GBGB9706667.4A external-priority patent/GB9706667D0/en
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2178759T3 publication Critical patent/ES2178759T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS HIDROXAMICOS, PERTENECIENTES A LA FAMILIA DE LAS DIAMIDAS DE ACIDO 3 - IMINO 4 - OXO - 1,7 - DIOICO (7 - N - HIDROXI), CARACTERIZADOS POR LA PRESENCIA DE UN GRUPO OXIMETILO EN POSICION 6. LOS COMPUESTOS PREFERIDOS TIENEN LA FORMULA (I), DONDE R 1 ES UN SUSTITUYEN TE DE FORMULA (II): A - (O - CR 5 H) N ) M . A - R2 , R 3 , R 4 , R 5 , M Y N SON TAL Y COMO SE DEFINEN EN LA DESCRIPCION. LOS PRESENTES COMPUESTOS SON UTILES EN SUSTANCIAS FARMACEUTICAS, P.EJ. PARA SUPRIMIR LA LIBERACION DEL TNF Y PARA EL TRATAMIENTO DE ENFERMEDADES AUTOINMUNES E INFLAMATORIAS, P.EJ. LA ESCLEROSIS MULTIPLE Y LA ARTRITIS REUMATOIDE, Y PRESENTAN UNA BIODISPONIBILIDAD INCREMENTADA. ASIMISMO, SE DESCRIBEN PROCEDIMIENTOS DE PREPARACION DE DICHOS COMPUESTOS, ASI COMO INTERMEDIARIOS DE LOS MISMOS Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
ES97909339T 1996-10-02 1997-09-30 Derivados de acido hidroxamico. Expired - Lifetime ES2178759T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9620572.9A GB9620572D0 (en) 1996-10-02 1996-10-02 Organic compounds
GBGB9706667.4A GB9706667D0 (en) 1997-04-02 1997-04-02 Organic compounds

Publications (1)

Publication Number Publication Date
ES2178759T3 true ES2178759T3 (es) 2003-01-01

Family

ID=26310147

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97909339T Expired - Lifetime ES2178759T3 (es) 1996-10-02 1997-09-30 Derivados de acido hidroxamico.

Country Status (29)

Country Link
EP (1) EP0929517B1 (es)
JP (1) JP3444898B2 (es)
KR (1) KR20000048811A (es)
CN (1) CN1101807C (es)
AR (1) AR009103A1 (es)
AT (1) ATE219050T1 (es)
AU (1) AU726065B2 (es)
BR (1) BR9712255A (es)
CA (1) CA2267415A1 (es)
CO (1) CO4900034A1 (es)
CZ (1) CZ113999A3 (es)
DE (1) DE69713354T2 (es)
DK (1) DK0929517T3 (es)
ES (1) ES2178759T3 (es)
HK (1) HK1021637A1 (es)
HU (1) HUP9903892A3 (es)
ID (1) ID22212A (es)
IL (1) IL129166A0 (es)
MY (1) MY127926A (es)
NO (1) NO313457B1 (es)
NZ (1) NZ334908A (es)
PE (1) PE2099A1 (es)
PL (1) PL188518B1 (es)
PT (1) PT929517E (es)
RU (1) RU2196131C2 (es)
SI (1) SI0929517T1 (es)
SK (1) SK43099A3 (es)
TR (1) TR199900725T2 (es)
WO (1) WO1998014424A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003294917A1 (en) * 2002-12-20 2004-07-14 Novartis Ag Device and method for delivering mmp inhibitors
EP2287326A1 (en) 2003-08-08 2011-02-23 Arriva Pharmaceuticals, Inc. Methods of protein production in yeast
WO2005086915A2 (en) 2004-03-09 2005-09-22 Arriva Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
CN1951912B (zh) * 2005-10-18 2010-05-05 上海五洲药业股份有限公司 手性脂环烃异羟肟酸衍生物的制备方法
GB0818907D0 (en) * 2008-10-15 2008-11-19 Isis Innovation Histone lysine demethylase inhibitors
RU2021110237A (ru) * 2016-04-18 2021-05-06 Виворион Терапьютикс Аг Новые ингибиторы меприна альфа и бета

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9223904D0 (en) * 1992-11-13 1993-01-06 British Bio Technology Inhibition of cytokine production
DE19581347T1 (de) * 1994-01-20 1996-12-05 British Biotech Pharm Metalloproteinase-Inhibitoren
WO1995019961A1 (en) * 1994-01-22 1995-07-27 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
GB9416897D0 (en) * 1994-08-20 1994-10-12 British Biotech Pharm Metalloproteinase inhibitors
GB9423914D0 (en) * 1994-11-26 1995-01-11 British Biotech Pharm Polyether derivatives as metalloproteinase inhibitors

Also Published As

Publication number Publication date
HUP9903892A2 (hu) 2000-03-28
TR199900725T2 (xx) 1999-07-21
MY127926A (en) 2006-12-29
IL129166A0 (en) 2000-02-17
PL188518B1 (pl) 2005-02-28
SK43099A3 (en) 1999-08-06
RU2196131C2 (ru) 2003-01-10
PT929517E (pt) 2002-10-31
SI0929517T1 (en) 2002-10-31
NO991559D0 (no) 1999-03-30
KR20000048811A (ko) 2000-07-25
BR9712255A (pt) 1999-08-24
WO1998014424A1 (en) 1998-04-09
CA2267415A1 (en) 1998-04-09
AU726065B2 (en) 2000-10-26
PE2099A1 (es) 1999-02-08
DE69713354D1 (de) 2002-07-18
JP3444898B2 (ja) 2003-09-08
ID22212A (id) 1999-09-16
EP0929517B1 (en) 2002-06-12
NO991559L (no) 1999-03-30
CZ113999A3 (cs) 1999-06-16
ATE219050T1 (de) 2002-06-15
AU4706897A (en) 1998-04-24
NO313457B1 (no) 2002-10-07
AR009103A1 (es) 2000-03-08
JP2000508338A (ja) 2000-07-04
CN1232447A (zh) 1999-10-20
CO4900034A1 (es) 2000-03-27
HK1021637A1 (en) 2000-06-23
NZ334908A (en) 2000-10-27
DK0929517T3 (da) 2002-10-07
HUP9903892A3 (en) 2000-04-28
EP0929517A1 (en) 1999-07-21
PL332477A1 (en) 1999-09-13
DE69713354T2 (de) 2002-12-05
CN1101807C (zh) 2003-02-19

Similar Documents

Publication Publication Date Title
AR026410A1 (es) ''2-aril-3-(heteroaril)-imidazo[1,2-a]pirimidinas sustituidas, y las composiciones y metodos farmaceuticos relacionados
ES2044836T3 (es) Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene.
ES2051752T3 (es) Hidrocarbilfenatos de metales alcalinoterreos sulfurizados, su produccion y uso de los mismos.
FI864527A0 (fi) Tricyklofoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandning.
OA09468A (fr) Nouveaux dérivés du 1,2-benzisoxazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
PT1003504E (pt) Compostos quimicos
BR9713261A (pt) Tricìclicos substituìdos
IT1230859B (it) 2 alchinilfenoli sostituiti ad azione anti infiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
OA08336A (fr) Dérivés de type 13-halogéno-milbémycine et compositions les contenant.
NZ227039A (en) Benzofuran derivatives and anti-inflammatory compositions
ES2178759T3 (es) Derivados de acido hidroxamico.
AR001931A1 (es) Compuesto de 7-acilamino-3-iminometil (sustituido)cefalosporinas un proceso para su producción intermediarios en su producción una composición farmacéutica que contiene tales compuestos su utilizacióncomo compuestos farmacéuticos y un método para tratar enfermedades microbianas mediante administración de tales compuestos
RU93054165A (ru) Производные имидазопиридина, способ их получения, фармацевтическая композиция, способ лечения
AR010984A1 (es) Nuevos esteres de la pleuromutilina, y el acido 1-azabiciclo-4- carbanilcarbanico; procedimiento para su preparacion y composicionesfarmaceuticas que los contienen.
HUP9900767A2 (hu) Pirrolidinil-hidroxámsav-származékok és intermedierjeik, előállításuk és a vegyületeket tartalmazó gyógyászati készítmények
ES2109276T3 (es) Derivados de tropolona y composicion farmaceutica de los mismos para prevenir y tratar enfermedades isquemicas.
FR2744445B1 (fr) Composes biphenyles nouveaux et/ou a titre de medicament, compositions pharmaceutiques les contenant, leur procede de preparation et les intermediaires de ce procede
FR2707089B1 (fr) Nouveaux dérivés d'acide phosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ES544955A0 (es) Procedimiento para preparar derivados monobasicos de disobu-tamida
ES2052622T3 (es) Derivados de benzodioxol, compuestos que los comprenden y utilizacion de los mismos para la fabricacion de medicamentos.
AR019664A1 (es) Composicion para el tratamiento de enfermedades del cartilago
ES8302673A1 (es) Procedimiento para la preparacion de un 5-feniltetrazol
IL64018A0 (en) Cephalosporins,their production and pharmaceutical compositions containing them
GB2012260A (en) 4-desacetoxy-4 alpha -hydroxyindole- dihydroindoles, pharmaceutical formulations containing them and their use as antimitotic agents
ECSP972275A (es) Derivados de acidos hidroxamico